The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | A | Alimentary tract and metabolism | |
2 | A07 | Antidiarrheals, intestinal antiinflammatory/antiinfective agents | |
3 | A07E | Intestinal antiinflammatory agents | |
4 | A07EA | Corticosteroids acting locally |
Code | Title | |
---|---|---|
A07EA01 | Prednisolone | |
A07EA02 | Hydrocortisone | |
A07EA03 | Prednisone | |
A07EA04 | Betamethasone | |
A07EA05 | Tixocortol | |
A07EA06 | Budesonide | |
A07EA07 | Beclometasone |
Active Ingredient | Description | |
---|---|---|
Beclometasone |
Beclometasone is a pro-drug with weak glucocorticoid receptor binding affinity. It is extensively hydrolysed via esterase enzymes to the active metabolite beclometasone-17-monopropionate (B-17-MP), which has potent topical anti-inflammatory activity. |
|
Betamethasone |
Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. |
|
Budesonide |
Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers. |
|
Hydrocortisone |
Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates. |
|
Prednisolone |
Prednisolone is a glucocorticoid which has anti-inflammatory activity. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used for their potent anti-inflammatory effects in disorders of many organ systems. |
|
Prednisone |
Prednisone is a synthetic glucocorticoid with anti-inflammatory and immunomodulating properties. After cell surface receptor attachment and cell entry, prednisone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production. This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cell populations. |
|
Tixocortol |
Tixocortol is a 21-thiol derivative of hydrocortisone classified as a class A corticosteroid. It is a synthetic steroid with topical anti-inflammatory properties without the systemic glucocorticoid and mineralocorticoid activities and toxicity. |
Title | Information Source | Document Type | |
---|---|---|---|
BETNESOL Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
BUDENOFALK Gastro-resistant capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
BUDENOFALK Rectal foam | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
CLIPPER Gastro-resistant prolonged-release tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
CORTENEMA Enema | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
ENTOCORT CR Capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
ENTOCORT Dispersible tablet and solution for rectal suspension | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
KINPEYGO Modified-release hard capsule | European Medicines Agency (EU) | MPI, EU: SmPC |